To Assess the efficacy of Laghumanjisthadi Kashaya and Mahatrinaka Taila in Eczema Management

Randomized controlled trial to evaluate the efficacy of Laghumanjisthadi kashaya and Mahatrinaka Taila in the management of Vicharchika W.S.R to Eczema - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069830

Enrollment

Registered

2024-07-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients age between 18-60 years, irrespective of sex. 2. Patients having clinical signs and symptoms of Eczema like pruritis, oozing, Eruptions, Discoloration, Dryness, Thickening of skin. 3. Patients having chronicity less than 5 years

Exclusion criteria

Exclusion criteria: 1. Patients below the age of 18 years and above 60 years. 2.Patients with Steroid and cytotoxic treatment greater than 5 years 3.Patient having concomitant illness like HIV, Malignancy. 4.Pregnant or lactating women. 5.Patient participated in any clinical trial for last 6 months

Design outcomes

Primary

Measure	Time frame
changes in EASI score from the baseline value after Four weeksTimepoint: At baseline and after 4 weeks	—

Secondary

Measure	Time frame
changes in following parameters- â?¢ Change in intensity of itching, roughness of skin, oozing from lesion site , skin eruptions, skin discoloration from the baseline value after 4 weeks. â?¢ Change in QOL using DLQI ( Dermatology Life Quality Index)Timepoint: At baseline and end of 28 days treatment	—

Countries

India

Contacts

Public ContactDr Pravin Shamrao Sawant

National Institute of Ayurveda, Deemed to be university, Jaipur

drsawantps@gmail.com9890275426

Outcome results